Calvin H. Knowlton - May 18, 2021 Form 4 Insider Report for Tabula Rasa HealthCare, Inc. (TRHC)

Role
Chief Executive Officer, Director
Signature
/s/ Brian W. Adams, by Power of Attorney
Stock symbol
TRHC
Transactions as of
May 18, 2021
Transactions value $
-$1,388,708
Form type
4
Date filed
5/20/2021, 09:06 PM
Next filing
Jun 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TRHC Common Stock Sale -$491K -12K -1.41% $40.95 841K May 18, 2021 Direct F1, F2
transaction TRHC Common Stock Sale -$416K -10.2K -1.21% $40.76 831K May 19, 2021 Direct F1, F3
transaction TRHC Common Stock Sale -$73.7K -1.79K -0.22% $41.20 829K May 19, 2021 Direct F1, F4
transaction TRHC Common Stock Sale -$407K -10K -1.39% $40.74 707K May 20, 2021 Held by spouse. F5, F6
holding TRHC Common Stock 20K May 18, 2021 Held by trust for children.
holding TRHC Common Stock 20K May 18, 2021 Held by trust for children.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $40.38 to $41.33, inclusive. The reporting person undertakes to provide to Tabula Rasa HealthCare, Inc., any security holder of Tabula Rasa HealthCare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2), (3) (4) and (6) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $40.10 to $41.09, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $41.12 to $41.30, inclusive.
F5 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Orsula Knowlton on May 12, 2021.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $40.34 to $41.33 inclusive.